Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Emma Scott.
Newcastle Authors
Title
Year
Full text
Dr Emma Scott
Professor Craig Robson
A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid ‘xenoautoantigen’ Neu5Gc in humans and the need for a standardised approach to quantification
2024
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
2024
Zainab Alebady
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Emma Lishman-Walker
Jesslyn Choo
et al.
CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer
2023
Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al.
Engineering prostate cancer in vitro: what does it take?
2023
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al.
Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer
2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
2023
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al.
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
2023
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al.
The role of GCNT1 mediated
O
-glycosylation in aggressive prostate cancer
2023
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al.
Upregulation of GALNT7 in prostate cancer modifies
O
-glycosylation and promotes tumour growth
2023
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
et al.
Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer
2022
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Fut8 alpha-(1,6)-fucosyltransferase in cancer
2021
Dr Jack Leslie
Dr Emma Scott
Professor Quentin Anstee
Professor Fiona Oakley
Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma
2021
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Tumour associated glycans: A route to boost immunotherapy?
2020
Dr Jennifer Munkley
SR Gokul Krishnan
Gerald Hysenaj
Dr Emma Scott
Caroline Dalgliesh
et al.
Androgen-regulated transcription of
ESRP2
drives alternative splicing patterns in prostate cancer
2019
Rebecca Garnham
Dr Emma Scott
Karen Livermore
Dr Jennifer Munkley
ST6GAL1: A key player in cancer (Review)
2019
Dr Jennifer Munkley
Dr Emma Scott
Targeting Aberrant Sialylation to Treat Cancer
2019
Dr Emma Scott
Professor Quentin Anstee
The genetics of alcoholic liver disease and non-alcoholic steatohepatitis
2018
Dr Emma Scott
Dr Jeremy Palmer
Professor Quentin Anstee
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in
TM6SF2
E167K variant carriers with NAFLD
2017